Equities

Neurones SA

Neurones SA

Actions
TechnologyTechnology
  • Price (EUR)42.55
  • Today's Change1.20 / 2.90%
  • Shares traded6.77k
  • 1 Year change+17.54%
  • Beta0.4728
Data delayed at least 15 minutes, as of Sep 19 2024 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Neurones SA is a France-based company, which provides information technology (IT) services. It operates within three areas: consulting, integration of technological solutions and outsourcing of information systems. The business lines are organized into three centers: Infrastructures Business, Consulting Business and Applications Business. Within the Infrastructures area, the Company provides design, integration and operation of system and networks, service desk, production engineering services, as well as remote servers and application operations and asset management consulting. As per the Applications business line, Neurones SA offers analysis, expertise and software development as well as support and third-party application maintenance. Consulting business line provides development, maintenance of applications, trainings, among others. The Company operates through several subsidiaries, including Axones SAS, Arondor, AS Delivery, AS International and Edugroupe.

  • Revenue in EUR (TTM)774.91m
  • Net income in EUR48.49m
  • Incorporated1985
  • Employees6.85k
  • Location
    Neurones SANanterre CedexNANTERRE 92024FranceFRA
  • Phone+33 141374137
  • Fax+33 147244046
  • Websitehttps://www.neurones.net
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Infotel SA307.55m18.07m273.92m1.96k15.052.319.710.89072.622.6244.6517.101.19--4.21157,152.307.186.6412.5011.9499.9399.906.025.68----0.214975.682.375.83-11.033.68-1.784.56
Sword Group SE298.89m20.11m359.37m2.23k17.693.8212.491.202.132.1331.629.841.150.49488.74134,940.407.9017.8112.4025.4990.3892.566.8818.130.986612.440.391888.495.8310.95-79.21-22.48-16.987.21
Aubay SA534.12m33.41m528.46m7.59k15.902.0213.700.98942.542.5440.6820.011.18158.743.3468,661.277.407.7712.0213.0875.3078.296.256.611.72--0.07937.234.015.92-6.234.10-2.8414.87
Quadient SA1.06bn82.40m565.98m4.72k6.820.52833.130.53272.412.0131.0831.080.41083.534.65225,037.103.261.684.302.1774.1773.217.934.551.145.170.436243.82-0.8123-0.5463724.00-0.04852.864.17
Equasens SA219.79m47.05m705.60m1.24k15.003.1911.583.213.103.1014.4814.590.59027.054.42177,248.4012.8112.8718.2418.3668.5468.6921.7120.761.13--0.227342.222.678.161.7313.0910.718.02
Neurones SA774.91m48.49m1.00bn6.85k20.752.8713.471.301.991.9931.8514.411.190.43024.62114,819.108.887.9615.3613.0599.9199.917.467.402.24--0.104869.0411.398.6311.6813.7420.9482.06
Lectra SA500.31m31.94m1.06bn2.95k33.433.4316.202.120.83760.837613.128.170.5892.005.55196,200.403.515.285.217.7370.9869.625.977.960.65798.870.3145.91-8.5011.07-23.623.36-11.03-2.09
Ovh Groupe SA944.05m-30.98m1.17bn2.92k--2.953.741.24-0.1608-0.16084.902.080.5931--23.46327,453.00-1.95-2.42-2.54-3.2878.4878.30-3.28-4.00--0.22040.6807--13.8711.89-41.21--3.23--
Wavestone SA701.06m58.20m1.27bn4.48k18.992.2017.971.812.692.6932.6923.160.9258--3.32156,520.707.748.2911.1312.5690.3394.988.368.50--44.550.128515.6131.7112.3616.2413.5916.5010.56
Exclusive Networks SAS1.51bn41.00m2.15bn2.71k52.142.1818.861.430.44970.449716.5310.760.47635.031.39591,516.101.300.41142.360.674132.6715.722.720.52191.044.070.3696---54.20--19.44------
Alten SA4.07bn233.21m3.41bn57.00k14.381.6510.340.83856.746.74117.5658.771.20--3.2171,382.416.889.0510.5613.9888.9689.535.737.32----0.15315.807.5512.38-49.038.124.348.45
Sopra Steria Group SA5.91bn240.50m3.81bn56.00k15.851.918.490.644411.709.45287.2096.960.9929--4.31105,933.804.003.887.606.6975.5280.744.033.81--13.800.452231.9013.807.23-25.877.9910.2020.24
Data as of Sep 19 2024. Currency figures normalised to Neurones SA's reporting currency: Euro EUR

Institutional shareholders

10.55%Per cent of shares held by top holders
HolderShares% Held
Invesco Advisers, Inc.as of 31 Jul 20241.20m4.94%
Myria Asset Management SASUas of 31 Jul 2024218.33k0.90%
Gay-Lussac Gestion SAas of 31 Dec 2023214.54k0.88%
Grandeur Peak Global Advisors LLCas of 30 Apr 2024170.98k0.70%
Financi�re de l'�chiquier SAas of 31 May 2024155.39k0.64%
Janus Henderson Investors UK Ltd.as of 30 Jun 2024128.74k0.53%
Cr�dit Mutuel Asset Management SAas of 30 Jun 2023128.00k0.53%
Allianz Global Investors GmbHas of 30 Nov 2023125.14k0.52%
Sycomore Asset Management SAas of 31 Jul 2024111.69k0.46%
Tocqueville Finance SAas of 29 Sep 2023111.39k0.46%
More ▼
Data from 31 Dec 2023 - 30 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.